Laboratory tests of a novel serotonin-binding compound have revealed an unexpected disconnect between receptor activation and behavior, raising new questions about how psychedelic effects emerge in the brain.
In past studies, psychedelic drugs have usually produced a predictable behavioral response in mice. Activation of the brain’s serotonin 5-HT2A receptor typically leads to rapid head-twitch movements, which researchers use as a standard indicator of hallucinogenic effects. When scientists administered a newly synthesized compound known as D5 to mice, this response did not occur.
Although D5 activated the same receptor associated with classic psychedelics, it did not cause head-twitch behavior. This result was unexpected for neuroscientists who study the connection between perception and serotonin signaling.
Researchers at the University of California-Davis and other collaborating institutions reported the finding in the Journal of the American Chemical Society. It raises a basic but unresolved question about how closely psychedelic effects are tied to the brain pathways believed to produce them.
Psychedelic Signaling Behavior
The 5-HT2A receptor is a central focus in psychedelic neuroscience. Well-known compounds like LSD and psilocybin bind to these receptors in the brain’s cortex, changing neural signaling in ways that can alter perception and shift consciousness.
This effect has been remarkably consistent in animals. Strong engagement of 5-HT2A almost always produces head-twitch responses, making the behavior a standard screening tool for hallucinogenic potential.
This consistent pattern has shaped expectations in psychedelic research. When a compound activates the receptor, researchers expect to see hallucinogenic effects. However, D5 did not fit this pattern.
An Exception to the Rule
The D5 compound was developed as part of an effort to explore chemical structures that are rarely studied in psychedelic research. Rather than modifying existing hallucinogens, the UC Davis team set out to create entirely new molecular scaffolds that could interact with serotonin in different ways.
“The question that we were trying to answer was, ‘Is there whole new class of drugs in this field that hasn’t been discovered?” said Joseph Beckett, a PhD student working with Professor Mark Mascal at the UC Davis Department of Chemistry.
The process began by combining amino acids with tryptamine, a molecule similar to serotonin. These new hybrids were then exposed to ultraviolet light, causing reactions that created new molecular shapes.
Computer modeling indicated that several of these compounds would likely bind effectively to 5-HT2A receptors. The researchers selected five candidates for laboratory testing. D5 was notable because it activated the receptor as strongly as known psychedelic compounds. Despite this, there were no apparent behavioral effects. In mice, D5 did not elicit head-twitch responses. This unexpected response indicates that activating 5-HT2A alone may not be sufficient to generate hallucinogenic effects.
A New Scaffold
Most drug candidates for psychedelic research are structurally similar to established compounds. However, the molecules described in this study do not resemble classic psychedelics in structure, and the researchers did not create them by making small changes to existing compounds.
“Completely new scaffolds are incredibly rare in this space,” said Trey Brasher, a co-author on the study. “This gives us a way to explore serotonin signaling that we didn’t have before.”
The authors note that this work is still in the early stages. So far, the researchers have only observed these behavioral effects in mice and have not tested the compounds in humans. It remains unknown why D5 fails to produce hallucinogenic-like behavior despite fully activating 5-HT2A receptors.
For now, the significance of the study lies in the questions it raises rather than in any immediate applications of the compounds. The long-standing assumption that strong activation of the brain’s main psychedelic receptor always changes perception is now uncertain.
Austin Burgess is a writer and researcher with a background in sales, marketing, and data analytics. He holds a Master of Business Administration, a Bachelor of Science in Business Administration, and a Data Analytics certification. His work combines analytical training with a focus on emerging science, aerospace, and astronomical research.